期刊文献+

人巨细胞病毒活动性感染及术前HBV感染与肝移植术后糖尿病初步研究 被引量:1

A research for post liver-transplantation diabetes mellitus,active human cytomegalovirus infection and preoperative HBV infection
下载PDF
导出
摘要 目的研究肝移植术后糖尿病与人巨细胞病毒(HCMV)活动性感染、术前HBV感染的关系。方法回顾性分析75例术前无糖尿病肝移植患者临床资料,观察患者移植术后糖尿病(post transplantation diabetes mellitus,PTDM)的发生、移植术后HCMV活动性感染及术前HBV感染的情况。结果PTDM发生率为17.3%(13/75)。术后HCMV活动性感染组PTDM发生率(23.1%)明显高于无活动性感染组(4.3%)(P【0.05)。术前HBV感染者PTDM发病率较未感染者高(21.1%与5.6%,P】0.05);HBVDNA与术后PTDM的发病无关(P】0.05);术前HBsAg(+)、HBeAg(+)、HBcAb(+)组,HBsAg(+)、HBeAb(+)、HBcAb(+)组,HBsAg(+)、HBcAb(+)组,发生PTDM情况无统计学差异(P】0.05)。结论肝移植术后糖尿病的发生可能与术后HCMV活动性感染有关,与术前HBV感染无关。 Objective To investigate the relationship between post liver-transplantation diabetes mellitus(PTDM) and active human cytomegalovirus(HCMV) infection, preoperative HBV infection,respectively.Methods The clinical data of 85 patients with liver transplantation were collected to analyze the incidence of PTDM,observe the active HCMV infection and preoperative HBV infection.Results The incidence rate of PTDM is 17.3%(13/75).The incidence of PTDM in patients with active HCMV infection after liver transplation (12/52,23.1%)is higher than that in patients without active HCMV infection(1/23,4.3%)(P<0.05).PTDM patients include 12 incidents of preoperative HBV infection(12/57, P>0.05),3 incidents of positive HBVDNA(3/57, P>0.05),2 incidents of positive HBsAg ,HBeAg and HBcAb(2/11, P>0.05), 5 incidents of positive HBsAg,HBeAb and HBcAb(5/24, P>0.05), 5 incidents of positive HBsAg and HBcAb(5/22, P>0.05).Conclusion PTDM may be relate to active HCMV infection after liver transplantation,unrelated to preoperative HBV infection.
出处 《浙江检验医学》 2008年第2期3-6,共4页 Zhejiang Journal of Laboratory Medicine
基金 国家自然科学基金(30471631)
关键词 肝移植 移植术后糖尿病(PTDM) 人巨细胞病毒(HCMV) HBV Liver transplantation Post transplantation diabetes mellitus(PTDM) Human cytomegalovirus(HCMV) HBV
  • 相关文献

参考文献13

  • 1范骏,郑林儿,杨美芳,高海女,陈晓明,胡敏君,范维薇,马伟杭.多种指标检测造血干细胞移植术后人巨细胞病毒活动性感染研究[J].中华检验医学杂志,2006,29(7):660-661. 被引量:6
  • 2马伟杭,徐陈槐,范骏,吴炜,陈智,郑树森.流式细胞技术在移植术后受者巨细胞病毒诊断上的应用[J].中华检验医学杂志,2002,25(1):20-22. 被引量:11
  • 3J. Hjelmes?th,S. Sagedal,A. Hartmann,H. Rollag,T. Egeland,M. Hagen,K. P. Nordal,T. Jenssen.Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation[J].Diabetologia.2004(9)
  • 4Marin M.,Renoult E,Bondor C.I.et al.Factors influencing the onset of diabetes mellitus after kidney transplantation:a single French center experience[].Transplantation.2005
  • 5Fabrizi F,,Lampertico P,Lunghi G,et al.Reviewarticle:hepatitis C virus infection and type\|2diabetes mellitus in renal diseases and transplantation[].Alimentary Pharmacology and Therapeutics.2005
  • 6Hodson EM,Jones CA,Webster AC,et al.Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid\|organ transplants:a systematic reviewof randomised controlled tri-als\[J\][].The Lancet.2005
  • 7Davidson J,Wilkinson A,Dantal J,et al.New\|onset diabetes af-ter transplantation:2003international consensus guidelines\[J\][].Transplantation.2003
  • 8Reisaeter AV,Hartmann.A.Risk factors and incidence of postt-ransplant diabetes mellitus\[J\][].Transplantation.2001
  • 9Hjelmeseth J,Mller F,Jenssen T,et al.Is there a link between cytomegalovirus infection and new\|onset posttransplantation dia-betes mellitus?Potential mechanisms of virus inducedβ\|cell damage\[J\][].Nephrology Dialysis Transplantation.2005
  • 10Sarin SK,Kumar M,Tyagi P.HBV carrier or chronic HBV infec-tion:need for change in terminology\[J\][].Journal of Gastroenter-ology and Hepatology.2004

二级参考文献13

  • 1Nguyen Q, Champlin R, Giranlt S, et al. Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients. Clin Infect Dis, 1999,28:618-623.
  • 2Kusne S, Shapiro R, Fung J. Prevention and treatment of cytomegalovirus infection in organ transplant recipients. Transplant Infect Dis,1999,1 :187-203.
  • 3Boeckh M, Bowden RA, Cooley T, et al. Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients.Blood, 1999,93 : 1781-1782.
  • 4Sia IG, Patel R. New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients. Clin Microbiol Rev,2000,13:83-121.
  • 5Howden BP, Michaalides A, Spelman DW. Cytomegalovirus viral load monitoring after allogeneie bone marrow transplantation in patients receiving antiviral prophylaxis. Bone Marrow Transplant.2003,32:795-800.
  • 6Ye Q, Luo G, He X, et al. Prospective study of relationship between cytomegalovirus pneumonia and viral load in renal transplant recipients. Transplant Proc ,2004,36:3036-3041.
  • 7Ghisetti V, Barbui A, Franchello A, et al. Quantitation of cytomegalovirus DNA by the polymerase chain reaction as a predictor of disease in solid organ transplantation. J Med Virol, 2004,73:223 -229.
  • 8Basso G, Timeus F. Cytofluorimetric analysis of CE34 cells. Bon Marrow Transplant, 1988,Suppl 5:S17-20.
  • 9Corver WE, Koopman LA, van der Aa, J, et al. Four-color multiparameter DNA flow, cytometric method to study phenotypic intratumor heterogeneity in cervical cancer. Cytometry, 2000,39:96-107.
  • 10Jiwa N, Mesker WE, Ploem Zadijer JT, et al. Quantification of low frequency white blood cells expressing human cytomegalovirus antigen by image cytometry. Cytometry, 1994,16:69-73.

共引文献15

同被引文献37

  • 1林伟良,刘文虎,徐冉行,凌志强.糖尿病患者外周血白细胞HCMV pp65基因表达状态研究[J].中国感染控制杂志,2006,5(4):298-302. 被引量:1
  • 2Zanone MM, Favaro E, Quadri R, et al. Association of cytomegalovirus infections with recurrence of humoral and cellular autoimmunity to islet autoantigens and of type 1 diabetes in a pancreas transplanted patient[J]. Transpl Int, 2010, 23(3): 333-337.
  • 3GinsbergFellner F, Witt ME, Yagihashi S, et al. Congenital rubella syndrome as a model for type 1 (insulindependent) diabetes mellitus: increased prevalence of islet cell surface antibodies[J]. Diabetologia, 1984, 27(Suppl): 87-89.
  • 4Jenson AB, Rosenberg HS, Notkins AL. Pancreatic isletcell damage in children with fatal viral infections[J]. Lancet, 1980, 2(8190): 354-358.
  • 5Ward KP, Galloway WH, Auchterlonie I. Congenital cytomegalovirus infection and diabetes[J]. Lancet, 1979, 1(8114): 497.
  • 6Bissinger AL, Sinzger C, Kaiserling E, et al. Human cytomegalovirus as a direct pathogen: correlation of multiorgan involvement and cell distribution with clinical and pathological findings in a case of congenital inclusion disease[J]. J Med Virol, 2002, 67(2): 200-206.
  • 7Lohr JM, Oldstone MB. Detection of cytomegalovirus nucleic acid sequences in pancreas in type 2 diabetes[J]. Lancet, 1990, 336(8716): 644-648.
  • 8Mocarski ES Jr. Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion[J]. Trends Microbiol, 2002, 10(7): 332-339.
  • 9Sindre H, Rollag H, Olafsen MK, et al. Human cytomegalovirus induces apoptosis in the hematopoietic cell line MO7e[J]. APMIS, 2000, 108(3): 223-230.
  • 10Hiemstra HS, Schloot NC, van Veelen PA, et al. Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase[J]. Proc Natl Acad Sci U S A, 2001, 98(7): 3988-3991.

引证文献1

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部